HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹4.30 Cr | ₹33 Cr | ₹30 Cr | ₹33 Cr | ₹36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HIKAL ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹4.30 Cr |
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹36 Cr |
How is Deferred Tax Assets / Liabilities of HIKAL Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.30 Cr | -86.77 | |
| Mar2025 | ₹33 Cr | 8.33 | |
| Mar2024 | ₹30 Cr | -8.30 | |
| Mar2023 | ₹33 Cr | -10.14 | |
| Mar2022 | ₹36 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,401.3 Cr | -9.6% | -14.5% | -15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -9.6% |
-14.5% |
-15.5% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses